Johnson & Johnson Unveils Details On Ottava Soft-Tissue Robot, Chasing Intuitive, Medtronic
J&J said its Ottava robotic platform has six robotic arms, “zero footprint,” and can be used for various procedures.
You may also be interested in...
The company originally expected the first-in-human trial of the soft-tissue robotic surgery system to begin in late 2022 and reach the market by 2023, but the company now expects those trials to begin in 2024.
J&J expects its medical device sales to begin growing rapidly by the middle of 2021 as the pandemic subsides.
New published results demonstrate J&J/Auris’ robotic is safe and effective at diagnosing peripheral pulmonary lesions.